,BRCA1BRCA2使

Fahima Dossa1, Nancy N Baxter2,3,4,5, Rinku Sutradhar3,4,6

  • 1Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

PubMed
概括

随着时间的推移,公开资助的BRCA1/BRCA2突变基因测试增加了. 然而,该计划发现未受影响的女性较少,这表明需要改善高风险个体的早期检测以减少癌症风险.